Article
Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review)
1 Dec 2020
Abstract excerpt
Colorectal cancer (CRC) is the third most common malignant tumor in humans. Chemotherapy is used for the treatment of CRC. However, the effect of chemotherapy remains unsatisfactory due to drug resistance. Growing evidence has shown that the presence of highly metastatic tumor stem cells, regulation of non‑coding RNAs and the tumor microenvironment contributes to drug resistance mechanisms in CRC. Wnt/β‑catenin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
